CRRT is also effective in reducing BNP and circulating cytokines levels including IL-8 and monocyte chemoattractant protein-1 (MCP-1), as well as help patients regaining responsiveness to LDs in in a very small advanced HF population (5 patients) [33]. This evidence concerns the gene CXCL8 and hydrops fetalis.